<DOC>
	<DOCNO>NCT01823289</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety itraconazole sequential therapy ( intravenous injection/oral solution ) participant invasive pulmonary fungal infection ( [ IPFI ] ; lung disease cause fungal infection ) .</brief_summary>
	<brief_title>An Efficacy Safety Study Itraconazole Sequential Therapy ( Intravenous Injection Followed Oral Solution ) Invasive Pulmonary Fungal Infections</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , single arm , multicenter ( one hospital medical school team work medical research study ) study evaluate efficacy safety itraconazole sequential therapy participant IPFI . The study duration 4 6 week . The treatment divide intravenous ( vein ) injection period oral solution administration ( give ) period . During intravenous injection period 200 milligram ( mg ) twice daily load dose ( large initial dose ) give first 2 day , 200 mg daily subsequent 12 day . Then sequential itraconazole oral solution 200 mg twice daily give maintenance therapy ( treatment design help original primary treatment succeed ) 2-4 week . Participant 's clinical , mycological comprehensive efficacy assess Week 6 . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Lung Diseases , Fungal</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Probable proven invasive pulmonary infectious participant ( IPFI ) Hospitalized participant ( least hospitalize treatment observation could ensure intravenous injection period ) The participant ( legal representative ) sign informed consent form . Currently take taboo drug , terfenadine , astemizole , cisapride HMG CoA reductase inhibitor ( example simvastatin , lovastatin , oral intravenous midazolam triazolam ) History allergy intolerance imidazole pyrrole drug ( example fluconazole , itraconazole , ketoconazole , miconazole , clotrimazole ) Pregnant breast feed woman , woman child bear age take effective contraception measure Participants pure oral , urinary tract , vaginal candidiasis ( yeast infection ) Participants fungal meningitis ( inflammation meninges ) , active liver disease , renal insufficiency serum creatinine clearance rate le 30 milliliter per minute ( ml/min ) , current abnormal cardiac function congestive heart failure ( condition heart unable pump sufficient blood meet metabolic need body ) , participant history congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Invasive Pulmonary Fungal Infection</keyword>
	<keyword>Itraconazole</keyword>
</DOC>